160 related articles for article (PubMed ID: 25016196)
1. Next generation MRD.
Hourigan CS
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1259-60. PubMed ID: 25016196
[No Abstract] [Full Text] [Related]
2. Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.
Logan AC; Vashi N; Faham M; Carlton V; Kong K; Buño I; Zheng J; Moorhead M; Klinger M; Zhang B; Waqar A; Zehnder JL; Miklos DB
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1307-13. PubMed ID: 24769317
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.
Chamseddine AN; Willekens C; De Botton S; Bourhis JH
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S129-40. PubMed ID: 26297265
[TBL] [Abstract][Full Text] [Related]
4. The role of allogeneic HSCT after CAR T cells for acute lymphoblastic leukemia.
Jacoby E
Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):810-814. PubMed ID: 31431700
[TBL] [Abstract][Full Text] [Related]
5. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Bachanova V; Weisdorf D
Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
[TBL] [Abstract][Full Text] [Related]
6. The role of allografting in adults with acute leukaemia.
Marks DI
Bone Marrow Transplant; 2008 Mar; 41(5):413-4. PubMed ID: 18334991
[No Abstract] [Full Text] [Related]
7. Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia.
Kato K; Kato M; Hasegawa D; Kawasaki H; Ishida H; Okamoto Y; Koh K; Inoue M; Inagaki J; Kato K; Sakamaki H; Yabe H; Kawa K; Suzuki R; Atsuta Y
Blood; 2015 Feb; 125(8):1352-4. PubMed ID: 25700427
[No Abstract] [Full Text] [Related]
8. Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".
Bachanova V
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S10-S15. PubMed ID: 28760293
[No Abstract] [Full Text] [Related]
9. Allogeneic transplantation for ALL in adults.
Stein A; Forman SJ
Bone Marrow Transplant; 2008 Mar; 41(5):439-46. PubMed ID: 18334992
[TBL] [Abstract][Full Text] [Related]
10. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
[TBL] [Abstract][Full Text] [Related]
11. Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia.
Corker E; Astwood E; Williams J; Vora A
Br J Haematol; 2012 Oct; 159(1):104-6. PubMed ID: 22804487
[No Abstract] [Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.
Marks DI; Alonso L; Radia R
Hematol Oncol Clin North Am; 2014 Dec; 28(6):995-1009. PubMed ID: 25459175
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation.
Hua J; Zhang J; Wu X; Zhou L; Bao X; Han Y; Miao M; Li C; Fu Z; Wu D; Qian W; Qiu H
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):610-616. PubMed ID: 32507386
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.
Hamilton BK; Rybicki L; Abounader D; Adekola K; Advani A; Aldoss I; Bachanova V; Bashey A; Brown S; DeLima M; Devine S; Flowers CR; Ganguly S; Jagasia M; Kennedy VE; Kim DDH; McGuirk J; Pullarkat V; Romee R; Sandhu K; Smith M; Ueda M; Viswabandya A; Vu K; Wall S; Zeichner SB; Perales MA; Majhail NS
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1117-1121. PubMed ID: 28396160
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.
Yoon JH; Min GJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Lee S
Cancer; 2019 Mar; 125(6):873-883. PubMed ID: 30521062
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.
Mitsuhashi K; Kako S; Shigematsu A; Atsuta Y; Doki N; Fukuda T; Kanamori H; Onizuka M; Takahashi S; Ozawa Y; Kurokawa M; Inoue Y; Nagamura-Inoue T; Morishima Y; Mizuta S; Tanaka J;
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2194-2200. PubMed ID: 27638362
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia.
Fielding AK; Goldstone AH
Bone Marrow Transplant; 2008 Mar; 41(5):447-53. PubMed ID: 17968326
[TBL] [Abstract][Full Text] [Related]
18. New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL.
Pulsipher MA; Wayne AS; Schultz KR
Bone Marrow Transplant; 2014 Oct; 49(10):1259-65. PubMed ID: 24933210
[TBL] [Abstract][Full Text] [Related]
19. The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia.
Kebriaei P; Poon LM
Curr Hematol Malig Rep; 2012 Jun; 7(2):144-52. PubMed ID: 22410763
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
Merli P; Algeri M; Del Bufalo F; Locatelli F
Curr Hematol Malig Rep; 2019 Apr; 14(2):94-105. PubMed ID: 30806963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
